FitProven
Evidence Breakdown
Based on 8 studies
THE BIGGER QUESTION
Whether this one statement holds is settled above. What to actually do about it is a wider question, weighed across every claim that bears on it.
Evidence map
For & against, at a glance
Meta-Analysis
Pro
López-Bueno R et al. · 2022Ageing Research ReviewsSystematic review with dose-response meta-analysis of 48 prospective cohort studies in healthy adults, pooling 3,135,473 participants (49.6% women, aged 35-85). It found a significant inverse association between handgrip strength and all-cause, cancer and cardiovascular mortality, and mapped the shape of the relationship rather than just its direction. Risk of all-cause mortality fell in a close-to-linear fashion across roughly 26-50 kg of grip strength; cardiovascular mortality fell across roughly 24-40 kg; cancer mortality showed a U-shaped pattern with benefit concentrated between about 16 and 33 kg. Heterogeneity was substantial for the cause-specific outcomes (I² 77-80%). The dose-response shape differs by cause of death, which the authors flag as evidence that grip strength is not tracking a single mechanism.
0.90
Systematic review with dose-response meta-analysis of 48 prospective cohort studies in healthy adults, pooling 3,135,473 participants (49.6% women, aged 35-85). It found a significant inverse association between handgrip strength and all-cause, cancer and cardiovascular mortality, and mapped the shape of the relationship rather than just its direction. Risk of all-cause mortality fell in a close-to-linear fashion across roughly 26-50 kg of grip strength; cardiovascular mortality fell across roughly 24-40 kg; cancer mortality showed a U-shaped pattern with benefit concentrated between about 16 and 33 kg. Heterogeneity was substantial for the cause-specific outcomes (I² 77-80%). The dose-response shape differs by cause of death, which the authors flag as evidence that grip strength is not tracking a single mechanism.
Design Meta-Analysis (1.0) × quality 0.90 = impact 0.90
View sourceMeta-Analysis
Pro
Wu Y et al. · 2017Journal of the American Medical Directors AssociationMeta-analysis of 42 prospective cohort studies pooling 3,002,203 community-dwelling participants, examining grip strength against all-cause mortality, cardiovascular disease and cancer. Comparing the lowest with the highest category of grip strength, the pooled hazard ratios were 1.41 (95% CI 1.30-1.52) for all-cause mortality and 1.63 (1.36-1.96) for cardiovascular disease; the association with cancer was null (0.89, 0.66-1.20). Per 5 kg decrease in grip strength, the hazard ratios were 1.16 (1.12-1.20) for all-cause mortality, 1.21 (1.14-1.29) for cardiovascular disease, 1.09 (1.05-1.14) for stroke and 1.07 (1.03-1.11) for coronary heart disease — a per-5-kg figure that lands exactly on the PURE estimate. Results were consistent across sexes and persisted after excluding participants with cardiovascular disease or cancer at baseline, which weakens (though does not eliminate) reverse causation as an explanation. All pooled studies are observational, so the design cannot establish that raising grip strength lowers risk.
0.85
Meta-analysis of 42 prospective cohort studies pooling 3,002,203 community-dwelling participants, examining grip strength against all-cause mortality, cardiovascular disease and cancer. Comparing the lowest with the highest category of grip strength, the pooled hazard ratios were 1.41 (95% CI 1.30-1.52) for all-cause mortality and 1.63 (1.36-1.96) for cardiovascular disease; the association with cancer was null (0.89, 0.66-1.20). Per 5 kg decrease in grip strength, the hazard ratios were 1.16 (1.12-1.20) for all-cause mortality, 1.21 (1.14-1.29) for cardiovascular disease, 1.09 (1.05-1.14) for stroke and 1.07 (1.03-1.11) for coronary heart disease — a per-5-kg figure that lands exactly on the PURE estimate. Results were consistent across sexes and persisted after excluding participants with cardiovascular disease or cancer at baseline, which weakens (though does not eliminate) reverse causation as an explanation. All pooled studies are observational, so the design cannot establish that raising grip strength lowers risk.
Design Meta-Analysis (1.0) × quality 0.85 = impact 0.85
View sourceMeta-Analysis
Neutral
Momma H et al. · 2022British Journal of Sports MedicineSystematic review and meta-analysis of 16 prospective cohort studies examining muscle-strengthening activity (resistance training) and major non-communicable disease outcomes. Any muscle-strengthening activity versus none was associated with a 10-17% lower risk of all-cause mortality, cardiovascular disease, total cancer, diabetes and lung cancer, independent of aerobic activity. The dose-response was J-shaped for most outcomes, with the maximum risk reduction (roughly 10-20%) at about 30-60 minutes per week and no further benefit — possibly attenuation — beyond that; for diabetes the curve was L-shaped. The exposure here is whole-body strength training as reported in questionnaires, not grip-specific training, and the design remains observational.
0.60
Systematic review and meta-analysis of 16 prospective cohort studies examining muscle-strengthening activity (resistance training) and major non-communicable disease outcomes. Any muscle-strengthening activity versus none was associated with a 10-17% lower risk of all-cause mortality, cardiovascular disease, total cancer, diabetes and lung cancer, independent of aerobic activity. The dose-response was J-shaped for most outcomes, with the maximum risk reduction (roughly 10-20%) at about 30-60 minutes per week and no further benefit — possibly attenuation — beyond that; for diabetes the curve was L-shaped. The exposure here is whole-body strength training as reported in questionnaires, not grip-specific training, and the design remains observational.
Design Meta-Analysis (1.0) × quality 0.60 = impact 0.60
View sourceMeta-Analysis
Neutral
Oliveira PC et al. · 2023Journal of Human HypertensionSystematic review and meta-analysis of 9 randomized controlled trials of isometric handgrip exercise in people with hypertension — 2 trials of a single acute session and 7 of chronic training programmes. Repeated isometric handgrip training reduced resting systolic blood pressure by 6.7 mmHg (95% CI -10.3 to -3.4) and diastolic blood pressure by 4.5 mmHg (95% CI -7.3 to -1.7); a single session had no significant effect. This is, as of this writing, essentially the only randomized evidence that deliberately squeezing a handgrip device changes any health outcome at all. The outcome measured is a surrogate marker — blood pressure — over trial durations of weeks to months; no trial in this literature measured mortality, survival, or any hard clinical endpoint.
0.60
Systematic review and meta-analysis of 9 randomized controlled trials of isometric handgrip exercise in people with hypertension — 2 trials of a single acute session and 7 of chronic training programmes. Repeated isometric handgrip training reduced resting systolic blood pressure by 6.7 mmHg (95% CI -10.3 to -3.4) and diastolic blood pressure by 4.5 mmHg (95% CI -7.3 to -1.7); a single session had no significant effect. This is, as of this writing, essentially the only randomized evidence that deliberately squeezing a handgrip device changes any health outcome at all. The outcome measured is a surrogate marker — blood pressure — over trial durations of weeks to months; no trial in this literature measured mortality, survival, or any hard clinical endpoint.
Design Meta-Analysis (1.0) × quality 0.60 = impact 0.60
View sourceMeta-Analysis
Pro
López-Bueno R et al. · 2022Ageing Research ReviewsSystematic review with dose-response meta-analysis of 48 prospective cohort studies in healthy adults, pooling 3,135,473 participants (49.6% women, aged 35-85). It found a significant inverse association between handgrip strength and all-cause, cancer and cardiovascular mortality, and mapped the shape of the relationship rather than just its direction. Risk of all-cause mortality fell in a close-to-linear fashion across roughly 26-50 kg of grip strength; cardiovascular mortality fell across roughly 24-40 kg; cancer mortality showed a U-shaped pattern with benefit concentrated between about 16 and 33 kg. Heterogeneity was substantial for the cause-specific outcomes (I² 77-80%). The dose-response shape differs by cause of death, which the authors flag as evidence that grip strength is not tracking a single mechanism.
0.90
Systematic review with dose-response meta-analysis of 48 prospective cohort studies in healthy adults, pooling 3,135,473 participants (49.6% women, aged 35-85). It found a significant inverse association between handgrip strength and all-cause, cancer and cardiovascular mortality, and mapped the shape of the relationship rather than just its direction. Risk of all-cause mortality fell in a close-to-linear fashion across roughly 26-50 kg of grip strength; cardiovascular mortality fell across roughly 24-40 kg; cancer mortality showed a U-shaped pattern with benefit concentrated between about 16 and 33 kg. Heterogeneity was substantial for the cause-specific outcomes (I² 77-80%). The dose-response shape differs by cause of death, which the authors flag as evidence that grip strength is not tracking a single mechanism.
Design Meta-Analysis (1.0) × quality 0.90 = impact 0.90
View sourceMeta-Analysis
Pro
Wu Y et al. · 2017Journal of the American Medical Directors AssociationMeta-analysis of 42 prospective cohort studies pooling 3,002,203 community-dwelling participants, examining grip strength against all-cause mortality, cardiovascular disease and cancer. Comparing the lowest with the highest category of grip strength, the pooled hazard ratios were 1.41 (95% CI 1.30-1.52) for all-cause mortality and 1.63 (1.36-1.96) for cardiovascular disease; the association with cancer was null (0.89, 0.66-1.20). Per 5 kg decrease in grip strength, the hazard ratios were 1.16 (1.12-1.20) for all-cause mortality, 1.21 (1.14-1.29) for cardiovascular disease, 1.09 (1.05-1.14) for stroke and 1.07 (1.03-1.11) for coronary heart disease — a per-5-kg figure that lands exactly on the PURE estimate. Results were consistent across sexes and persisted after excluding participants with cardiovascular disease or cancer at baseline, which weakens (though does not eliminate) reverse causation as an explanation. All pooled studies are observational, so the design cannot establish that raising grip strength lowers risk.
0.85
Meta-analysis of 42 prospective cohort studies pooling 3,002,203 community-dwelling participants, examining grip strength against all-cause mortality, cardiovascular disease and cancer. Comparing the lowest with the highest category of grip strength, the pooled hazard ratios were 1.41 (95% CI 1.30-1.52) for all-cause mortality and 1.63 (1.36-1.96) for cardiovascular disease; the association with cancer was null (0.89, 0.66-1.20). Per 5 kg decrease in grip strength, the hazard ratios were 1.16 (1.12-1.20) for all-cause mortality, 1.21 (1.14-1.29) for cardiovascular disease, 1.09 (1.05-1.14) for stroke and 1.07 (1.03-1.11) for coronary heart disease — a per-5-kg figure that lands exactly on the PURE estimate. Results were consistent across sexes and persisted after excluding participants with cardiovascular disease or cancer at baseline, which weakens (though does not eliminate) reverse causation as an explanation. All pooled studies are observational, so the design cannot establish that raising grip strength lowers risk.
Design Meta-Analysis (1.0) × quality 0.85 = impact 0.85
View sourceMeta-Analysis
Neutral
Momma H et al. · 2022British Journal of Sports MedicineSystematic review and meta-analysis of 16 prospective cohort studies examining muscle-strengthening activity (resistance training) and major non-communicable disease outcomes. Any muscle-strengthening activity versus none was associated with a 10-17% lower risk of all-cause mortality, cardiovascular disease, total cancer, diabetes and lung cancer, independent of aerobic activity. The dose-response was J-shaped for most outcomes, with the maximum risk reduction (roughly 10-20%) at about 30-60 minutes per week and no further benefit — possibly attenuation — beyond that; for diabetes the curve was L-shaped. The exposure here is whole-body strength training as reported in questionnaires, not grip-specific training, and the design remains observational.
0.60
Systematic review and meta-analysis of 16 prospective cohort studies examining muscle-strengthening activity (resistance training) and major non-communicable disease outcomes. Any muscle-strengthening activity versus none was associated with a 10-17% lower risk of all-cause mortality, cardiovascular disease, total cancer, diabetes and lung cancer, independent of aerobic activity. The dose-response was J-shaped for most outcomes, with the maximum risk reduction (roughly 10-20%) at about 30-60 minutes per week and no further benefit — possibly attenuation — beyond that; for diabetes the curve was L-shaped. The exposure here is whole-body strength training as reported in questionnaires, not grip-specific training, and the design remains observational.
Design Meta-Analysis (1.0) × quality 0.60 = impact 0.60
View sourceMeta-Analysis
Neutral
Oliveira PC et al. · 2023Journal of Human HypertensionSystematic review and meta-analysis of 9 randomized controlled trials of isometric handgrip exercise in people with hypertension — 2 trials of a single acute session and 7 of chronic training programmes. Repeated isometric handgrip training reduced resting systolic blood pressure by 6.7 mmHg (95% CI -10.3 to -3.4) and diastolic blood pressure by 4.5 mmHg (95% CI -7.3 to -1.7); a single session had no significant effect. This is, as of this writing, essentially the only randomized evidence that deliberately squeezing a handgrip device changes any health outcome at all. The outcome measured is a surrogate marker — blood pressure — over trial durations of weeks to months; no trial in this literature measured mortality, survival, or any hard clinical endpoint.
0.60
Systematic review and meta-analysis of 9 randomized controlled trials of isometric handgrip exercise in people with hypertension — 2 trials of a single acute session and 7 of chronic training programmes. Repeated isometric handgrip training reduced resting systolic blood pressure by 6.7 mmHg (95% CI -10.3 to -3.4) and diastolic blood pressure by 4.5 mmHg (95% CI -7.3 to -1.7); a single session had no significant effect. This is, as of this writing, essentially the only randomized evidence that deliberately squeezing a handgrip device changes any health outcome at all. The outcome measured is a surrogate marker — blood pressure — over trial durations of weeks to months; no trial in this literature measured mortality, survival, or any hard clinical endpoint.
Design Meta-Analysis (1.0) × quality 0.60 = impact 0.60
View sourceShowing the 4 strongest of 8 studies. Tap any node to expand its detail.
Evidence
PRO (5)
PRO Prospective Cohortn=5022930.95 Celis-Morales CA, Welsh P et al. (2018)
Per 5 kg lower grip strength: all-cause mortality HR 1.20 (women) / 1.16 (men); cardiovascular mortality 1.19 / 1.22; respiratory 1.31 / 1.24; cancer 1.17 / 1.10
UK Biobank prospective cohort of 502,293 participants aged 40-69 (54% women), followed for a mean of 7.1 years for mortality. In fully adjusted models, each 5 kg lower grip strength was associated with higher all-cause mortality (HR 1.20 in women, 1.16 in men), cardiovascular mortality (1.19 / 1.22), respiratory disease (1.31 / 1.24), COPD (1.24 / 1.19) and cancer mortality (1.17 / 1.10) — associations that were modestly stronger in younger participants. Progressive adjustment for comorbidities, lifestyle and dietary factors attenuated the associations only slightly, and a landmark analysis excluding events in the first two years produced similar results, arguing against reverse causation from occult disease as the whole explanation. The authors nevertheless present grip strength as a prognostic biomarker, not as a modifiable cause, and note residual confounding cannot be excluded.
Weighted 0.95 — 502,293 participants with a mean 7.1 years of follow-up — as large and as well-powered as this literature gets, publicly funded (Wellcome Trust, MRC, Department of Health) with no declared competing interests. Progressive adjustment barely attenuated the associations and a landmark analysis excluding the first two years argues against reverse causation. Top of its design class; the residual-confounding limit is inherent to the cohort design itself, which the study-type base weight already accounts for.
Funding: independent
The BMJ
PRO Prospective Cohortn=1396910.90 Leong DP, Teo KK et al. (2015)
Each 5 kg lower grip strength was associated with 16% higher all-cause mortality (HR 1.16, 95% CI 1.13-1.20), 17% higher cardiovascular death (HR 1.17), 7% higher myocardial infarction (HR 1.07) and 9% higher stroke (HR 1.09) -- a stronger predictor of mortality than systolic blood pressure
The Prospective Urban Rural Epidemiology (PURE) study measured handgrip strength with a Jamar dynamometer in 139,691 adults aged 35-70 across 17 countries spanning all income levels, then followed them for a median of 4.0 years (IQR 2.9-5.1). After adjustment for age, sex, education, employment, physical activity, tobacco and alcohol use, each 5 kg reduction in grip strength was associated with a 16% higher risk of all-cause mortality (HR 1.16, 95% CI 1.13-1.20), a 17% higher risk of cardiovascular death (HR 1.17, 1.11-1.24), a 17% higher risk of non-cardiovascular death (HR 1.17, 1.12-1.21), and modestly higher risks of myocardial infarction (HR 1.07, 1.02-1.11) and stroke (HR 1.09, 1.05-1.15). Grip strength was a stronger predictor of all-cause and cardiovascular mortality than systolic blood pressure — the finding that made the study famous. It was not associated with most non-cardiovascular causes of death individually, and the authors explicitly noted that the mechanisms linking grip strength to mortality remain unclear and that it may be a marker of overall muscle and general health rather than a causal factor.
Weighted 0.90 — 139691 adults across 17 countries and every income level, median 4.0 years of follow-up, standardised Jamar dynamometry and extensive adjustment -- about as strong as a prospective cohort gets, and the authors declare no competing interests despite the long commercial funder list (the pharma grants are unrestricted and the funder had no role). The remaining limits are inherent to the design: residual confounding, and a short follow-up that leaves reverse causation (occult illness weakening grip) plausible. The authors themselves conclude grip is likely a MARKER of general health rather than a causal factor, so it is indirect evidence for any claim that TRAINING grip strength extends life.
The Lancet
PRO Meta-Analysisn=31354730.90 López-Bueno R, Andersen LL et al. (2022)
inverse dose-response between grip strength and mortality — all-cause risk falls near-linearly across ~26-50 kg, cardiovascular across ~24-40 kg; cancer mortality is U-shaped
Systematic review with dose-response meta-analysis of 48 prospective cohort studies in healthy adults, pooling 3,135,473 participants (49.6% women, aged 35-85). It found a significant inverse association between handgrip strength and all-cause, cancer and cardiovascular mortality, and mapped the shape of the relationship rather than just its direction. Risk of all-cause mortality fell in a close-to-linear fashion across roughly 26-50 kg of grip strength; cardiovascular mortality fell across roughly 24-40 kg; cancer mortality showed a U-shaped pattern with benefit concentrated between about 16 and 33 kg. Heterogeneity was substantial for the cause-specific outcomes (I² 77-80%). The dose-response shape differs by cause of death, which the authors flag as evidence that grip strength is not tracking a single mechanism.
Weighted 0.90 — k=48 prospective cohorts, 3,135,473 participants across more than 40 countries. Newcastle-Ottawa quality was good in 38 of 48 studies (mean 7.5/9) and every study entering the quantitative analyses was good quality; no funnel-plot asymmetry. Funded entirely by public/academic sources (EU NextGenerationEU, ANID Chile, Government of Andalusia) with no industry involvement. Limits: observational throughout, high heterogeneity for the cause-specific outcomes (I2 77-80%), and high-income countries are overrepresented.
Funding: independent
Ageing Research Reviews
PRO Prospective Cohortn=83620.90 Westbury LD, Harvey NC et al. (2024)
Per SD decrease, grip strength HR 1.14 (95% CI 1.10-1.19) and gait speed HR 1.21 (1.17-1.26) predicted mortality; appendicular lean mass index did not (HR 1.01, 0.95-1.06). Adding all sarcopenia components to age+sex raised the C-index only from 0.65 to 0.67
Pooled prospective analysis of three community cohorts (Health ABC, MrOS, Hertfordshire) totalling 8,362 older adults (mean age 73.8), followed a median of 13.3 years with 5,231 deaths, testing how much each component of sarcopenia contributes to predicting death. Per standard deviation decrease, grip strength (HR 1.14, 95% CI 1.10-1.19) and gait speed (HR 1.21, 1.17-1.26) were independently associated with mortality after extensive adjustment, while appendicular lean mass index — i.e. muscle quantity — was not (HR 1.01, 0.95-1.06). Critically, the study also quantified how much predictive information grip strength actually adds: a model with age and sex alone achieved a C-index of 0.65 (0.64-0.66), and adding all sarcopenia components including grip strength raised it only to 0.67 (0.67-0.68). The authors conclude these measures offer "only minimal improvement" in discriminating who will die beyond routinely available risk factors.
Weighted 0.90 — 8,362 older adults pooled from three cohorts, median 13.3 years of follow-up and 5,231 deaths — large, well-powered, extensively adjusted, and unusual in that it quantifies how little its own marker adds rather than just reporting a hazard ratio. Publicly funded, though several co-authors carry extensive personal pharmaceutical disclosures unrelated to this analysis. Observational, so reverse causation cannot be excluded.
Funding: US National Institute on Aging / NIH (Health ABC, MrOS) and the UK Medical Research Council (Hertfordshire Cohort Study)
Aging Clinical and Experimental Research
PRO Meta-Analysisn=30022030.85 Wu Y, Wang W et al. (2017)
Lowest vs highest grip strength: all-cause mortality HR 1.41 (95% CI 1.30-1.52), cardiovascular disease HR 1.63 (1.36-1.96), cancer null (0.89, 0.66-1.20). Per 5 kg decrease, all-cause mortality HR 1.16 (1.12-1.20)
Meta-analysis of 42 prospective cohort studies pooling 3,002,203 community-dwelling participants, examining grip strength against all-cause mortality, cardiovascular disease and cancer. Comparing the lowest with the highest category of grip strength, the pooled hazard ratios were 1.41 (95% CI 1.30-1.52) for all-cause mortality and 1.63 (1.36-1.96) for cardiovascular disease; the association with cancer was null (0.89, 0.66-1.20). Per 5 kg decrease in grip strength, the hazard ratios were 1.16 (1.12-1.20) for all-cause mortality, 1.21 (1.14-1.29) for cardiovascular disease, 1.09 (1.05-1.14) for stroke and 1.07 (1.03-1.11) for coronary heart disease — a per-5-kg figure that lands exactly on the PURE estimate. Results were consistent across sexes and persisted after excluding participants with cardiovascular disease or cancer at baseline, which weakens (though does not eliminate) reverse causation as an explanation. All pooled studies are observational, so the design cannot establish that raising grip strength lowers risk.
Weighted 0.85 — 42 prospective cohorts and 3,002,203 participants — about as well-powered and consistent as this literature gets, and the associations survive excluding participants with baseline cardiovascular disease or cancer. Two things hold it back: every pooled study is observational, so it cannot show that raising grip strength lowers risk, and the null for cancer alongside strong all-cause and CVD associations is the pattern frailty confounding would produce. No funding statement is retrievable.
Journal of the American Medical Directors Association
NEUTRAL (3)
NEUTRAL Expert Opinion0.60 Sayer AA, Kirkwood TBL (2015)
Argues grip strength's prognostic power reflects it acting as a biomarker of biological ageing -- an integrated readout of nutrition, muscle mass, neuromuscular function and inflammation -- rather than an organ-specific causal risk factor; explicitly treats the causal question as open
Invited Lancet Comment, published alongside the PURE grip strength paper, by two senior researchers in ageing and geriatric medicine. It argues that grip strength's remarkable prognostic performance is best understood as grip strength functioning as a biomarker of biological ageing — an integrated readout of nutrition, muscle mass, neuromuscular function, inflammation and accumulated cellular damage — rather than as an organ-specific risk factor in the way that blood pressure or cholesterol are. The authors call for research into the mechanisms underlying the association and into whether grip strength can be usefully modified, explicitly treating the causal question as open. This is expert commentary, not primary data.
Weighted 0.60 — No sample size: this is an invited Lancet Comment, not primary data. Rated high within the expert-opinion class because it is by two leading authorities in ageing research, in a top-tier journal, published alongside the PURE data it discusses, and because it is appropriately cautious -- it argues against over-reading the association causally rather than for a commercial or partisan position. Funding/COI statement not retrievable (paywalled), so omitted.
The Lancet
NEUTRAL Meta-Analysis0.60 Momma H, Kawakami R et al. (2022)
any muscle-strengthening activity vs none was associated with 10-17% lower risk of all-cause mortality, cardiovascular disease, total cancer, diabetes and lung cancer, independent of aerobic activity, with maximum risk reduction at about 30-60 min/week and no further benefit beyond that
Systematic review and meta-analysis of 16 prospective cohort studies examining muscle-strengthening activity (resistance training) and major non-communicable disease outcomes. Any muscle-strengthening activity versus none was associated with a 10-17% lower risk of all-cause mortality, cardiovascular disease, total cancer, diabetes and lung cancer, independent of aerobic activity. The dose-response was J-shaped for most outcomes, with the maximum risk reduction (roughly 10-20%) at about 30-60 minutes per week and no further benefit — possibly attenuation — beyond that; for diabetes the curve was L-shaped. The exposure here is whole-body strength training as reported in questionnaires, not grip-specific training, and the design remains observational.
Weighted 0.60 — k=16 prospective cohorts. No single pooled participant total is reported — the per-outcome samples run from 202,486 (diabetes) to 540,543 (total cancer), with individual cohorts of 3,809 to 479,856 — so sample_size is omitted rather than invented. The decisive limitation is the authors' own GRADE rating: certainty of evidence was "very low" for most outcomes and only "low" for diabetes, because the exposure is self-reported questionnaire data and every included study is observational. Publicly funded, no competing interests. The exposure is whole-body strength training, not grip-specific training.
Funding: Japanese Ministry of Health, Labour and Welfare (grant JPMH20FA1006)
British Journal of Sports Medicine
NEUTRAL Meta-Analysis0.60 Oliveira PC, Silva MR et al. (2023)
Isometric handgrip training reduced resting systolic blood pressure by 6.7 mmHg (95% CI -10.3 to -3.4) and diastolic by 4.5 mmHg (95% CI -7.3 to -1.7); a single acute session had no effect
Systematic review and meta-analysis of 9 randomized controlled trials of isometric handgrip exercise in people with hypertension — 2 trials of a single acute session and 7 of chronic training programmes. Repeated isometric handgrip training reduced resting systolic blood pressure by 6.7 mmHg (95% CI -10.3 to -3.4) and diastolic blood pressure by 4.5 mmHg (95% CI -7.3 to -1.7); a single session had no significant effect. This is, as of this writing, essentially the only randomized evidence that deliberately squeezing a handgrip device changes any health outcome at all. The outcome measured is a surrogate marker — blood pressure — over trial durations of weeks to months; no trial in this literature measured mortality, survival, or any hard clinical endpoint.
Weighted 0.60 — Only k=9 RCTs (7 of training, 2 acute) and the pooled participant total is not reported anywhere in the accessible record, so precision cannot be judged; the constituent trials are small and run for weeks to months. RoB2 and GRADE were applied, which is a strength. The outcome is a surrogate (blood pressure) — no trial in this literature measured a hard clinical endpoint. Funding could not be verified (paywalled).
Journal of Human Hypertension